AstraZeneca PLC Settles Seroquel Case; Agrees to Pay $520 Million to Settle Investigation

April 27, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Reuters -- Drug maker AstraZeneca has agreed to pay $520 million to settle a federal investigation into its marketing practices for the antipsychotic drug Seroquel, the New York Times reported on its website on Monday.

Twitter
LinkedIn
Facebook
Email
Print

Legal

AstraZeneca Pharmaceuticals LP